Centrilobular fibrosis: An underrecognized pattern in systemic sclerosis

Respiration

Volumn 77, Issue 4, 2009, Pages 389-397

  De Souza, Romy B C ^a   Borges, Claudia T L ^a   Capelozzi, Vera L ^a   Parra, Edwin R ^a   Jatene, Fabio B ^a   Kavakama, Jorge ^a   Kairalla, Ronaldo A ^a   Bonfá, Eloisa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Centrilobular fibrosis; Foreign bodies; Gastroesophageal reflux; Interstitial lung disease; Systemic sclerosis; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BRONCHIOLITIS; CENTRILOBULAR FIBROSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSPNEA; ESOPHAGUS DISEASE; FEMALE; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LESION; OPEN LUNG BIOPSY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE;

ADULT; ANTIRHEUMATIC AGENTS; CYCLOPHOSPHAMIDE; ESOPHAGUS; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67650089743     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000156958     Document Type: Article

References (39)

1. Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaque J, Vilardell M: Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatolog y (Oxford) 2003; 42: 71-75.
2. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H, van den Hoogen F, Te Boome L, van Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM: Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005; 118:2-10.
3. Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA Jr: Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis R heum 1985; 28: 759-767.
4. McCarthy DS, Baragar FD, Dhingra S, Sigurdson M, Sutherland JB, Rigby M, Martin L: The lungs in systemic sclerosis (scleroderma): a review and new information. Semin Arthritis Rheum 1988; 17 : 271-283.
5. Bryan C, Knight C, Black CM, Silman AJ: Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999; 42:2660-2665.
6. Fujita J, Yoshinouchi T, Ohtsuki Y, Tokuda M, Yang Y, Yamadori I, Bandoh S, Ishida T, Takahara J, Ueda R: Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann Rheum Dis 2001; 60: 281-283.
7. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM: Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165:1581-1586.
8. Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, Kitiaichi M: The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19:121- 127.
9. American Thoracic Society; European Respiratory Society: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165:277-304.
10. Denis P, Ducrotte P, Pasquis P, Lefrancois R: Esophageal motility and pulmonary function in progressive systemic sclerosis. Respiration 1981; 42:21-24.
11. Johnson DA, Drane WE, Curran J, Cattau EL Jr, Ciarleglio C, Khan A, Cotelingam J, Benjamin SB: Pulmonary disease in progressive systemic sclerosis: a complication of gastroesophageal reflux and occult aspiration? Arch Intern Med 1989; 149 : 589-593.
12. Lock G, Pfeifer M, Straub RH, Zeuner M, Lang B, Scholmerich J, Holstege A: Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis. Am J Gastroenterol 1998; 93:341-345.
13. Marie I, Dominique S, Levesque H, Ducrotte P, Denis P, Hellot MF, Courtois H: Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001; 45:346-354.
14. Ing AJ: Interstitial lung disease and gastroesophageal reflux. Am J Med 2001; 111(suppl 8A):41S-44S.
15. Moran TJ: Experimental aspiration pneumonia. IV. Inflammatory and reparative changes produced by intratracheal injections of autologous gastric juice and hydrochloric acid. AMA Arch Pathol 1955; 60:122- 129.
16. Donnelly RJ, Berrisford RG, Jack CI, Tran JA, Evans CC: Simultaneous tracheal and esophageal pH monitoring: investigating reflux-associated asthma. Ann Thorac Surg 1993; 56:1029-1033.
17. Ducolone A, Vandevenne A, Jouin H, Grob JC, Coumaros D, Meyer C, Burghard G, Methlin G, Hollender L: Gastroesophageal reflux in patients with asthma and chronic bronchitis. Am Rev Respir Dis 1987; 135:327- 332.
18. Mansfield LE: Gastroesophageal reflux and diseases of the respiratory tract: a review. J Asthma 1989; 26:271-278.
19. Schnatz PF, Castell JA, Castell DO: Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol 1996; 91: 1715-1718.
20. Shimizu Y, Dobashi K, Zhao JJ, Kawata T, Ono A, Yanagitani N, Kaira K, Utsugi M, Hisada T, Ishizuka T, Mori M: Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease. Respiration 2007; 74: 558-564.
21. Kiljander TO, Salomaa ER, Hietanen EK, Ovaska J, Helenius H, Liippo K: Gastroesophageal reflux and bronchial responsiveness: correlation and the effect of fundoplication. Respiration 2002; 69:434-439.
22. de Carvalho ME, Kairalla RA, Capelozzi VL, Deheinzelin D, do Nascimento Saldiva PH, de Carvalho CR: Centrilobular fibrosis: a novel histological pattern of idiopathic interstitial pneumonia. Pathol Res Pract 2002; 198:577-583.
23. Barnes TW, Vassallo R, Tazelaar HD, Hartman TE, Ryu JH: Diffuse bronchiolar disease due to chronic occult aspiration. Mayo Clin Proc 2006; 81:172-176.
24. Mukhopadhyay S, Katzenstein AL: Pulmonary disease due to aspiration of food and other particulate matter: a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens. Am J Surg Pathol 2007; 31: 752-759.
25. Tung KT, Wells AU, Rubens MB, Kirk JM, du Bois RM, Hansell DM: Accuracy of the typical computed tomographic appearances of f ibrosing a lveolitis. Thora x 1993; 48: 334- 338.
26. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Art hritis Rheum 1980; 23: 581-590.
27. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J R heumatol 1988; 15 : 202-205.
28. Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D'Angelo WA, Lachenbruch PA, Grau RG, Seibold JR: The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998; 25:84-88.
29. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144 : 1202-1218.
30. Cotes JE, Dabbs JM, Elwood PC, Hall AM, McDonald A, Saunders MJ: Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusion capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 1972; 42:325-335.
31. Matsuse T, Oka T, Kida K, Fukuchi Y: Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly. Chest 1996; 110:1289-1293.
32. Mays EE, Dubois JJ, Hamilton GB: Pulmonary fibrosis associated with tracheobronchial aspiration: a study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 1976; 69: 512-515.
33. Tutuian R: Update in the diagnosis of gastroesophageal reflux disease. J Gastrointestin Liver Dis 2006; 15: 243-247.
34. Raghu G: The role of gastroesophageal reflux in idiopathic pulmonary fibrosis. Am J Med 2003; 115(suppl 3A):60S- 64S.
35. Tobin RW, Pope CE 2nd, Pellegrini CA, Emond MJ, Sillery J, Raghu G: Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 1804- 1808.
36. D'Ovidio F, Singer LG, Hadjiliadis D, Pierre A, Waddell TK, de Perrot M, Hutcheon M, Miller L, Darling G, Keshavjee S: Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg 2005; 80:1254-1260.
37. Raghu G, Yang ST, Spada C, Hayes J, Pellegrini CA: Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest 2006; 129:794- 800.
38. Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE 2nd, Pellegrini CA: High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006; 27: 136-142.
39. Meloni F, Caporali R, Marone Bianco A, Paschetto E, Morosini M, Fietta AM, Patrizio V, Bobbio-Pallavicini F, Pozzi E, Montecucco C: BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21:111-118.